FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Source/Disclosures Published by: sources: Belandres C, et al. New virus on the block: Introducing infection control processes for mpox patients
Read MoreSource/Disclosures Disclosures: Hadland receives funding from the National Institute on Drug Abuse. Guss and Solomon report no financial disclosures. Please
Read MoreHepatitis C virus BSIP | UIG | Getty Images The overwhelming majority of people in the US who have tested
Read MoreSource/Disclosures Disclosures: Shaikh reports receiving grants from the National Institute of Allergy and Infectious Diseases during the conduct of the
Read MoreSource/Disclosures Published by: sources: Palladino KJ, et al. Multidisciplinary implementation of published surgical site infection prevention recommendations is associated with
Read MoreFederal authorities charged a former Pfizer employee and his close friend Thursday with illegally trading shares based on non-public trial
Read MoreSource/Disclosures Published by: Disclosures: Kirchhoff reports no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new
Read MoreADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to
Read MoreIn this photo illustration, a box of the diabetes drug Ozempic rests on a pharmacy counter on April 17, 2023
Read MoreSource/Disclosures Published by: sources: Athanasiou-Kaatz N, et al. Clinical performance of a new multiplex PCR assay for detection of Sars-Cov-2,
Read More